The people living with hiv antiretroviral therapy coverage in Togo currently stands at 82%, which is 6% (7.9%) higher than 2021.
People living with HIV antiretroviral therapy coverage in Togo
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Togo
Antiretroviral therapy coverage
More indicators for Togo
Male unintentional poisoning
2.6
0.0
(2019)
Female wasting in children
5.3%
-0.3%
(2017)
Female prevalence of HIV
0.8%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar90
+intl dollar5
(2021)
Birth registration
82.9%
+4.9%
(2017)
Contraceptive modern method prevalence
21.4%
+4.1%
(2017)
Togo Antiretroviral therapy coverage between 2000 and 2022
| Period | Antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 82% | +6% |
| 2021 | 76% | +2% |
| 2020 | 74% | +5% |
| 2019 | 69% | +9% |
| 2018 | 60% | +6% |
| 2017 | 54% | +8% |
| 2016 | 46% | +7% |
| 2015 | 39% | +6% |
| 2014 | 33% | +3% |
| 2013 | 30% | +4% |
| 2012 | 26% | +2% |
| 2011 | 24% | +4% |
| 2010 | 20% | +7% |
| 2009 | 13% | +5% |
| 2008 | 8% | +2% |
| 2007 | 6% | +1% |
| 2006 | 5% | +1% |
| 2005 | 4% | +2% |
| 2004 | 2% | +1% |
| 2003 | 1% | +1% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |